This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

SCIENTIFIC LITERATURE

Thought leadership thanks to continuous commitment to R&D

Analytical Risk Assessment from validation results (AAPS 2015)

Gérald de FONTENAY, Jérôme RESPAUD, Pascal PUIG and Camille LEMAIRE

Read more

Novel drug formulation - Patent WO2015028637A1

Additional note : This patent is our client property & AmatsiSEPS does not receive any royalties  
Read more

Eye drop composition - Patent WO2013/107515A1

Goris Nesya, Neyts Johan, Blomsma Erwin, Wera Stefaan, Billiet Aino, Auwerx Joeri, Debeurme Veerle, Roe Maryline, Puig Pascal

Additional note: This patent is our client property & Amatsigroup does not receive any royalties
Read more
You have been succesfully registered
There has been a problem, try again later

In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species

Ebner T, al.

Read more

Recommendations on biomarker bioanalytical method validation by GCC

Richard Hougton, al.

Read more

Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)

Mark Boterman, al.

Read more

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please call me at
your phone number
or send an e-mail to
your e-mail address
and
leave your message.